1. Infants with evolving bronchopulmonary dysplasia demonstrate monocyte-specific expression of IL-1 in tracheal aspirates.
- Author
-
Eldredge LC, Creasy RS, Presnell S, Debley JS, Juul SE, Mayock DE, and Ziegler SF
- Subjects
- Bronchoalveolar Lavage Fluid chemistry, Bronchoalveolar Lavage Fluid immunology, Bronchopulmonary Dysplasia immunology, Bronchopulmonary Dysplasia pathology, Female, GPI-Linked Proteins deficiency, GPI-Linked Proteins genetics, GPI-Linked Proteins immunology, Gene Expression Regulation, Gestational Age, Humans, Infant, Infant, Newborn, Infant, Premature, Interleukin 1 Receptor Antagonist Protein immunology, Interleukin-1alpha immunology, Interleukin-1beta immunology, Lipopolysaccharide Receptors genetics, Lipopolysaccharide Receptors immunology, Male, Monocytes pathology, Pilot Projects, Prospective Studies, RNA, Messenger immunology, Receptors, IgG deficiency, Receptors, IgG genetics, Receptors, IgG immunology, Sequence Analysis, RNA, Signal Transduction, Trachea immunology, Trachea pathology, Bronchopulmonary Dysplasia genetics, Interleukin 1 Receptor Antagonist Protein genetics, Interleukin-1alpha genetics, Interleukin-1beta genetics, Monocytes immunology, RNA, Messenger genetics
- Abstract
Bronchopulmonary dysplasia (BPD) remains a devastating consequence of prematurity. Repeated inflammatory insults worsen lung injury, but there are no predictors for BPD-related respiratory outcomes or targeted therapies. We sought to understand inflammatory mechanisms in evolving BPD through molecular characterization of monocytes in tracheal aspirates from infants at risk for developing BPD. We performed flow cytometry targeting myeloid cell populations on prospectively collected tracheal aspirates from intubated patients born before 29 wk of gestation and <30 days old. We identified CD14
+ CD16+ (double-positive) and CD14+ CD16- (single-positive) monocytes and characterized their gene expression profiles by RNA sequencing and quantitative PCR. We further analyzed differential gene expression between time points to evaluate changes in monocyte function over the first weeks of life. Expression of IL-1A, IL-1B, and IL-1 receptor antagonist mRNA was increased in monocytes collected at day of life ( DOL ) 7 , DOL 14 , and DOL 28 compared with those collected at DOL 3 . This study suggests that early changes in monocyte-specific IL-1 cytokine pathways may be associated with evolving BPD.- Published
- 2019
- Full Text
- View/download PDF